These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24613849

  • 1. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles.
    Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC.
    Biochem Biophys Res Commun; 2014 Apr 04; 446(2):555-60. PubMed ID: 24613849
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of fluorescence in situ hybridization, p57 immunostaining, flow cytometry, and digital image analysis for diagnosing molar and nonmolar products of conception.
    Kipp BR, Ketterling RP, Oberg TN, Cousin MA, Plagge AM, Wiktor AE, Ihrke JM, Meyers CH, Morice WG, Halling KC, Clayton AC.
    Am J Clin Pathol; 2010 Feb 04; 133(2):196-204. PubMed ID: 20093228
    [Abstract] [Full Text] [Related]

  • 4. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
    McConnell TG, Norris-Kirby A, Hagenkord JM, Ronnett BM, Murphy KM.
    Am J Surg Pathol; 2009 Sep 04; 33(9):1409-15. PubMed ID: 19542869
    [Abstract] [Full Text] [Related]

  • 5. Human epidermal growth factor receptor 2 fluorescence in situ hybridization and P57KIP2 immunohistochemistry using tissue microarray: Improving histopathological subtyping of hydatidiform mole.
    López CL, Figueira Gouvêa AL, Rodrigues FR, Braga A, Valente Machado MD, Lopes VS.
    Placenta; 2020 Sep 15; 99():166-172. PubMed ID: 32810764
    [Abstract] [Full Text] [Related]

  • 6. Tetraploid partial hydatidiform mole: a case report and review of the literature.
    Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, Micetich K, Libby AL, Ronnett BM.
    Int J Gynecol Pathol; 2012 Jan 15; 31(1):73-9. PubMed ID: 22123726
    [Abstract] [Full Text] [Related]

  • 7. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
    Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM.
    Int J Gynecol Pathol; 2013 Mar 15; 32(2):199-214. PubMed ID: 23370656
    [Abstract] [Full Text] [Related]

  • 8. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
    Yang SM, You JF, Zhang XW, Zheng J, Liao SL.
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep 15; 38(9):580-4. PubMed ID: 20079184
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
    Landolsi H, Missaoui N, Brahem S, Hmissa S, Gribaa M, Yacoubi MT.
    Pathol Res Pract; 2011 Aug 15; 207(8):498-504. PubMed ID: 21767919
    [Abstract] [Full Text] [Related]

  • 11. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
    McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM.
    Am J Surg Pathol; 2009 Jun 15; 33(6):805-17. PubMed ID: 19145201
    [Abstract] [Full Text] [Related]

  • 12. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses.
    Merchant SH, Amin MB, Viswanatha DS, Malhotra RK, Moehlenkamp C, Joste NE.
    Hum Pathol; 2005 Feb 15; 36(2):180-6. PubMed ID: 15754295
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Combined p57KIP2 Immunohistochemistry and Fluorescent in situ Hybridization Analysis for Hydatidiform Moles Compared with Genotyping Diagnosis.
    Usui H, Hoshimoto K, Sato A, Kano M, Fukusato T, Nakatani Y, Shozu M.
    Int J Gynecol Pathol; 2024 Sep 01; 43(5):474-486. PubMed ID: 38291567
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
    Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA.
    Histopathology; 2004 Aug 01; 45(2):135-41. PubMed ID: 15279631
    [Abstract] [Full Text] [Related]

  • 18. Hydatidiform Moles: Ancillary Techniques to Refine Diagnosis.
    Ronnett BM.
    Arch Pathol Lab Med; 2018 Dec 01; 142(12):1485-1502. PubMed ID: 30500280
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous detection of imprinted gene expression (p57(KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies.
    Hoffner L, Parks WT, Swerdlow SH, Carson JC, Surti U.
    J Reprod Med; 2010 Dec 01; 55(5-6):219-28. PubMed ID: 20626178
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic value of p27 in comparison to p57 in differentiation between different gestational trophoblastic diseases.
    Abdou A, Kandil M, El-Wahed MA, Shabaan M, El-Sharkawy M.
    Fetal Pediatr Pathol; 2013 Dec 01; 32(6):395-411. PubMed ID: 23438793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.